2-206141952-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_005006.7(NDUFS1):​c.1251A>G​(p.Arg417Arg) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.31 in 1,607,042 control chromosomes in the GnomAD database, including 79,565 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.34 ( 9320 hom., cov: 32)
Exomes 𝑓: 0.31 ( 70245 hom. )

Consequence

NDUFS1
NM_005006.7 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 0.421

Publications

17 publications found
Variant links:
Genes affected
NDUFS1 (HGNC:7707): (NADH:ubiquinone oxidoreductase core subunit S1) The protein encoded by this gene belongs to the complex I 75 kDa subunit family. Mammalian complex I is composed of 45 different subunits. It locates at the mitochondrial inner membrane. This protein has NADH dehydrogenase activity and oxidoreductase activity. It transfers electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone. This protein is the largest subunit of complex I and it is a component of the iron-sulfur (IP) fragment of the enzyme. It may form part of the active site crevice where NADH is oxidized. Mutations in this gene are associated with complex I deficiency. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2011]
NDUFS1 Gene-Disease associations (from GenCC):
  • Leigh syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P
  • mitochondrial complex I deficiency, nuclear type 5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • mitochondrial disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Leigh syndrome with leukodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • mitochondrial complex I deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.49).
BP6
Variant 2-206141952-T-C is Benign according to our data. Variant chr2-206141952-T-C is described in ClinVar as Benign. ClinVar VariationId is 129695.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.421 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.438 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDUFS1NM_005006.7 linkc.1251A>G p.Arg417Arg synonymous_variant Exon 12 of 19 ENST00000233190.11 NP_004997.4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDUFS1ENST00000233190.11 linkc.1251A>G p.Arg417Arg synonymous_variant Exon 12 of 19 1 NM_005006.7 ENSP00000233190.5

Frequencies

GnomAD3 genomes
AF:
0.342
AC:
51977
AN:
151866
Hom.:
9315
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.444
Gnomad AMI
AF:
0.208
Gnomad AMR
AF:
0.294
Gnomad ASJ
AF:
0.354
Gnomad EAS
AF:
0.228
Gnomad SAS
AF:
0.240
Gnomad FIN
AF:
0.322
Gnomad MID
AF:
0.373
Gnomad NFE
AF:
0.311
Gnomad OTH
AF:
0.345
GnomAD2 exomes
AF:
0.307
AC:
77088
AN:
251248
AF XY:
0.302
show subpopulations
Gnomad AFR exome
AF:
0.445
Gnomad AMR exome
AF:
0.284
Gnomad ASJ exome
AF:
0.345
Gnomad EAS exome
AF:
0.230
Gnomad FIN exome
AF:
0.318
Gnomad NFE exome
AF:
0.317
Gnomad OTH exome
AF:
0.322
GnomAD4 exome
AF:
0.307
AC:
446709
AN:
1455058
Hom.:
70245
Cov.:
32
AF XY:
0.305
AC XY:
221147
AN XY:
724276
show subpopulations
African (AFR)
AF:
0.456
AC:
15165
AN:
33264
American (AMR)
AF:
0.288
AC:
12844
AN:
44664
Ashkenazi Jewish (ASJ)
AF:
0.347
AC:
9062
AN:
26084
East Asian (EAS)
AF:
0.214
AC:
8464
AN:
39626
South Asian (SAS)
AF:
0.247
AC:
21251
AN:
86020
European-Finnish (FIN)
AF:
0.320
AC:
17064
AN:
53372
Middle Eastern (MID)
AF:
0.387
AC:
2226
AN:
5758
European-Non Finnish (NFE)
AF:
0.309
AC:
341622
AN:
1106120
Other (OTH)
AF:
0.316
AC:
19011
AN:
60150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
14370
28740
43111
57481
71851
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
11078
22156
33234
44312
55390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.342
AC:
52018
AN:
151984
Hom.:
9320
Cov.:
32
AF XY:
0.339
AC XY:
25175
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.443
AC:
18363
AN:
41450
American (AMR)
AF:
0.295
AC:
4498
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.354
AC:
1230
AN:
3470
East Asian (EAS)
AF:
0.228
AC:
1175
AN:
5164
South Asian (SAS)
AF:
0.241
AC:
1164
AN:
4824
European-Finnish (FIN)
AF:
0.322
AC:
3393
AN:
10532
Middle Eastern (MID)
AF:
0.384
AC:
113
AN:
294
European-Non Finnish (NFE)
AF:
0.311
AC:
21170
AN:
67970
Other (OTH)
AF:
0.343
AC:
722
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1705
3410
5115
6820
8525
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
508
1016
1524
2032
2540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.322
Hom.:
18748
Bravo
AF:
0.348
Asia WGS
AF:
0.237
AC:
824
AN:
3476
EpiCase
AF:
0.326
EpiControl
AF:
0.326

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 22, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:2
-
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Leigh syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Mitochondrial complex I deficiency, nuclear type 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Mitochondrial complex I deficiency, nuclear type 5 Benign:1
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.49
CADD
Benign
12
DANN
Benign
0.70
PhyloP100
0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1801318; hg19: chr2-207006676; COSMIC: COSV51910175; API